deltatrials
Completed NCT02718586

Serum Level of Myokines and Protein Energy Wasting, Inflammation and Atherosclerosis in Hemodialysis Patients

Association of Serum Myokines and Protein Energy Wasting, Inflammation and Atherosclerotic Vascular Disease in Hemodialysis Patients

Sponsor: Tungs' Taichung Metroharbour Hospital

Updated 8 times since 2017 Last updated: Feb 15, 2017 Started: Mar 31, 2016 Primary completion: Dec 31, 2016 Completion: Dec 31, 2016

A observational or N/A phase clinical study on Protein-energy; Imbalance, this trial is completed. The trial is conducted by Tungs' Taichung Metroharbour Hospital and has accumulated 8 data snapshots since 2016. Longitudinal tracking of this trial contributes to a broader understanding of treatment development timelines.

Change History

8 versions recorded
  1. Sep 2024 — Present [monthly]

    Completed

  2. Jul 2024 — Sep 2024 [monthly]

    Completed

  3. Jan 2021 — Jul 2024 [monthly]

    Completed

  4. Sep 2020 — Jan 2021 [monthly]

    Completed

  5. Jun 2018 — Sep 2020 [monthly]

    Completed

Show 3 earlier versions
  1. Apr 2018 — Jun 2018 [monthly]

    Completed

    Phase: NANone

  2. Feb 2017 — Apr 2018 [monthly]

    Completed NA

    Status: Not Yet RecruitingCompleted

  3. Jan 2017 — Feb 2017 [monthly]

    Not Yet Recruiting NA

    First recorded

Mar 2016

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:
  • Tungs' Taichung Metroharbour Hospital
Data source: Tungs' Taichung Metroharbour Hospital

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

No location information available.